Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups

Hammurabi Bartuma, Ioannis Panagopoulos, Anna Collin, Domenico Trombetta, Henryk A. Domanski, Nils Mandahl, Fredrik Mertens

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typically through chromosomal rearrangements, of HMGA2 has an important role in the development of several mesenchymal neoplasms. These rearrangements result in the expression of a truncated protein lacking the acidic C-terminus, a fusion protein consisting of the AT-hook domains encoded by exons 1-3 and parts from another gene, or a full-length protein; loss of binding sites for regulatory microRNA molecules from the 3' untranslated region (UTR) of HMGA2 has been suggested to be a common denominator. Methods: Seventy adipocytic tumors, representing different morphologic and cytogenetic subgroups, were analyzed by qRT-PCR to study the expression status of HMGA2; 18 of these tumors were further examined by PCR to search for mutations or deletions in the 3'UTR. Results: Type (full-length or truncated) and level of expression varied with morphology and karyotype, with the highest levels in atypical lipomatous tumors and lipomas with rearrangements of 12q13-15 and the lowest in lipomas with 6p- or 13q-rearrangements, hibernomas, spindle cell lipomas and myxoid liposarcomas. All 18 examined tumors showed reduced or absent expression of the entire, or parts of, the 3'UTR, which was not due to mutations at the DNA level. Conclusion: In adipocytic tumors with deregulated HMGA2 expression, the 3'UTR is consistently lost, either due to physical disruption of HMGA2 or a shift to production of shorter 3'UTR.

Original languageEnglish
Article number36
JournalMolecular Cancer
Volume8
DOIs
Publication statusPublished - Jun 9 2009

Fingerprint

Cytogenetics
3' Untranslated Regions
Lipoma
Neoplasms
AT-Hook Motifs
Proteins
Myxoid Liposarcoma
Polymerase Chain Reaction
Sequence Deletion
MicroRNAs
Karyotype
Genes
Chromatin
Exons
Binding Sites
Mutation
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Oncology

Cite this

Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups. / Bartuma, Hammurabi; Panagopoulos, Ioannis; Collin, Anna; Trombetta, Domenico; Domanski, Henryk A.; Mandahl, Nils; Mertens, Fredrik.

In: Molecular Cancer, Vol. 8, 36, 09.06.2009.

Research output: Contribution to journalArticle

Bartuma, Hammurabi ; Panagopoulos, Ioannis ; Collin, Anna ; Trombetta, Domenico ; Domanski, Henryk A. ; Mandahl, Nils ; Mertens, Fredrik. / Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups. In: Molecular Cancer. 2009 ; Vol. 8.
@article{a347414997c945b889831943d444567d,
title = "Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups",
abstract = "Background: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typically through chromosomal rearrangements, of HMGA2 has an important role in the development of several mesenchymal neoplasms. These rearrangements result in the expression of a truncated protein lacking the acidic C-terminus, a fusion protein consisting of the AT-hook domains encoded by exons 1-3 and parts from another gene, or a full-length protein; loss of binding sites for regulatory microRNA molecules from the 3' untranslated region (UTR) of HMGA2 has been suggested to be a common denominator. Methods: Seventy adipocytic tumors, representing different morphologic and cytogenetic subgroups, were analyzed by qRT-PCR to study the expression status of HMGA2; 18 of these tumors were further examined by PCR to search for mutations or deletions in the 3'UTR. Results: Type (full-length or truncated) and level of expression varied with morphology and karyotype, with the highest levels in atypical lipomatous tumors and lipomas with rearrangements of 12q13-15 and the lowest in lipomas with 6p- or 13q-rearrangements, hibernomas, spindle cell lipomas and myxoid liposarcomas. All 18 examined tumors showed reduced or absent expression of the entire, or parts of, the 3'UTR, which was not due to mutations at the DNA level. Conclusion: In adipocytic tumors with deregulated HMGA2 expression, the 3'UTR is consistently lost, either due to physical disruption of HMGA2 or a shift to production of shorter 3'UTR.",
author = "Hammurabi Bartuma and Ioannis Panagopoulos and Anna Collin and Domenico Trombetta and Domanski, {Henryk A.} and Nils Mandahl and Fredrik Mertens",
year = "2009",
month = "6",
day = "9",
doi = "10.1186/1476-4598-8-36",
language = "English",
volume = "8",
journal = "Molecular Cancer",
issn = "1476-4598",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups

AU - Bartuma, Hammurabi

AU - Panagopoulos, Ioannis

AU - Collin, Anna

AU - Trombetta, Domenico

AU - Domanski, Henryk A.

AU - Mandahl, Nils

AU - Mertens, Fredrik

PY - 2009/6/9

Y1 - 2009/6/9

N2 - Background: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typically through chromosomal rearrangements, of HMGA2 has an important role in the development of several mesenchymal neoplasms. These rearrangements result in the expression of a truncated protein lacking the acidic C-terminus, a fusion protein consisting of the AT-hook domains encoded by exons 1-3 and parts from another gene, or a full-length protein; loss of binding sites for regulatory microRNA molecules from the 3' untranslated region (UTR) of HMGA2 has been suggested to be a common denominator. Methods: Seventy adipocytic tumors, representing different morphologic and cytogenetic subgroups, were analyzed by qRT-PCR to study the expression status of HMGA2; 18 of these tumors were further examined by PCR to search for mutations or deletions in the 3'UTR. Results: Type (full-length or truncated) and level of expression varied with morphology and karyotype, with the highest levels in atypical lipomatous tumors and lipomas with rearrangements of 12q13-15 and the lowest in lipomas with 6p- or 13q-rearrangements, hibernomas, spindle cell lipomas and myxoid liposarcomas. All 18 examined tumors showed reduced or absent expression of the entire, or parts of, the 3'UTR, which was not due to mutations at the DNA level. Conclusion: In adipocytic tumors with deregulated HMGA2 expression, the 3'UTR is consistently lost, either due to physical disruption of HMGA2 or a shift to production of shorter 3'UTR.

AB - Background: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typically through chromosomal rearrangements, of HMGA2 has an important role in the development of several mesenchymal neoplasms. These rearrangements result in the expression of a truncated protein lacking the acidic C-terminus, a fusion protein consisting of the AT-hook domains encoded by exons 1-3 and parts from another gene, or a full-length protein; loss of binding sites for regulatory microRNA molecules from the 3' untranslated region (UTR) of HMGA2 has been suggested to be a common denominator. Methods: Seventy adipocytic tumors, representing different morphologic and cytogenetic subgroups, were analyzed by qRT-PCR to study the expression status of HMGA2; 18 of these tumors were further examined by PCR to search for mutations or deletions in the 3'UTR. Results: Type (full-length or truncated) and level of expression varied with morphology and karyotype, with the highest levels in atypical lipomatous tumors and lipomas with rearrangements of 12q13-15 and the lowest in lipomas with 6p- or 13q-rearrangements, hibernomas, spindle cell lipomas and myxoid liposarcomas. All 18 examined tumors showed reduced or absent expression of the entire, or parts of, the 3'UTR, which was not due to mutations at the DNA level. Conclusion: In adipocytic tumors with deregulated HMGA2 expression, the 3'UTR is consistently lost, either due to physical disruption of HMGA2 or a shift to production of shorter 3'UTR.

UR - http://www.scopus.com/inward/record.url?scp=67650081458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650081458&partnerID=8YFLogxK

U2 - 10.1186/1476-4598-8-36

DO - 10.1186/1476-4598-8-36

M3 - Article

C2 - 19508721

AN - SCOPUS:67650081458

VL - 8

JO - Molecular Cancer

JF - Molecular Cancer

SN - 1476-4598

M1 - 36

ER -